Dr. Paul Adams joins La Jolla Pharmaceutical advisory board

La Jolla Pharmaceutical Company has named four physicians to its LJPC-401 advisory board, including gastroenterologist Paul Adams, MD.  

Advertisement

The LJPC-401 advisory board focuses on the company’s development of hepcidin. Dr. Adams is a professor of medicine and chief of gastroenterology at the University of Western Ontario in London, Ontario. The company also added:

•    Victor Gordeuk, MD
•    Ashutosh Lal, MD
•    Gordon McLaren, MD

More articles on gastroenterology:
Mutare Health names Dr. Lawrence Kosinski CMO
Ritter Pharmaceuticals names Gerald Proehl to board of directors
PPI therapy may increase risk of kidney injury in elderly

Advertisement

Next Up in GI & Endoscopy

  • Discontinuing GLP-1 treatment does not always cause significant weight gain, as many patients transition to other obesity or diabetes treatments,…

  • Health systems across the U.S. are continuing to expand outpatient digestive health services, with five new gastroenterology and endoscopy centers…

Advertisement

Comments are closed.